FONAR Corporation

NasdaqCM FONR

FONAR Corporation Price to Earnings Ratio (P/E) on January 14, 2025: 10.11

FONAR Corporation Price to Earnings Ratio (P/E) is 10.11 on January 14, 2025, a 40.11% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.
  • FONAR Corporation 52-week high Price to Earnings Ratio (P/E) is 10.98 on December 04, 2024, which is 8.66% above the current Price to Earnings Ratio (P/E).
  • FONAR Corporation 52-week low Price to Earnings Ratio (P/E) is 5.94 on May 20, 2024, which is -41.20% below the current Price to Earnings Ratio (P/E).
  • FONAR Corporation average Price to Earnings Ratio (P/E) for the last 52 weeks is 8.24.
Key data
Date Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S) Price to Book Ratio (P/B) Dividend Yield
Market news
Loading...
NasdaqCM: FONR

FONAR Corporation

CEO Mr. Timothy R. Damadian M.D.
IPO Date Oct. 29, 1981
Location United States
Headquarters 110 Marcus Drive
Employees 520
Sector Industrials
Industries
Description

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates through two segments, Medical Equipment segment, and Physician Management and Diagnostic services segment. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters and the development and implementation of practice growth and marketing strategies. The company owns and operates 5 diagnostic imaging facilities in Florida; and manages 39 MRI scanning facilities, including 25 facilities located in New York and 14 situated in Florida. It markets its scanners to private diagnostic imaging centers and hospitals. The company was incorporated in 1978 and is based in Melville, New York.

Similar companies

BDSX

Biodesix, Inc.

USD 1.15

-7.26%

XGN

Exagen Inc.

USD 3.00

-3.85%

SERA

Sera Prognostics, Inc.

USD 6.37

0.63%

BNR

Burning Rock Biotech Limited

USD 6.55

-6.69%

SHC

Sotera Health Company

USD 12.76

-2.52%

CSTL

Castle Biosciences, Inc.

USD 25.46

-2.64%

STIM

Neuronetics, Inc.

USD 2.16

-7.69%

StockViz Staff

January 15, 2025

Any question? Send us an email